Cargando…
Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21)
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Society for the Study of Obesity
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017332/ https://www.ncbi.nlm.nih.gov/pubmed/33518535 http://dx.doi.org/10.7570/jomes20133 |
| _version_ | 1783674044762030080 |
|---|---|
| author | Koo, Bo Kyung |
| author_facet | Koo, Bo Kyung |
| author_sort | Koo, Bo Kyung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-8017332 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Korean Society for the Study of Obesity |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-80173322021-04-02 Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21) Koo, Bo Kyung J Obes Metab Syndr Letter Korean Society for the Study of Obesity 2021-03-30 2021-02-01 /pmc/articles/PMC8017332/ /pubmed/33518535 http://dx.doi.org/10.7570/jomes20133 Text en Copyright © 2021 Korean Society for the Study of Obesity This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Letter Koo, Bo Kyung Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21) |
| title | Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21) |
| title_full | Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21) |
| title_fullStr | Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21) |
| title_full_unstemmed | Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21) |
| title_short | Letter: Effects of 6 Months of Dapagliflozin Treatment on Metabolic Profile and Endothelial Cell Dysfunction for Obese Type 2 Diabetes Mellitus Patients without Atherosclerotic Cardiovascular Disease (J Obes Metab Syndr 2020;29:215-21) |
| title_sort | letter: effects of 6 months of dapagliflozin treatment on metabolic profile and endothelial cell dysfunction for obese type 2 diabetes mellitus patients without atherosclerotic cardiovascular disease (j obes metab syndr 2020;29:215-21) |
| topic | Letter |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8017332/ https://www.ncbi.nlm.nih.gov/pubmed/33518535 http://dx.doi.org/10.7570/jomes20133 |
| work_keys_str_mv | AT koobokyung lettereffectsof6monthsofdapagliflozintreatmentonmetabolicprofileandendothelialcelldysfunctionforobesetype2diabetesmellituspatientswithoutatheroscleroticcardiovasculardiseasejobesmetabsyndr20202921521 |